Download Syllabus - Angelina College

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Polysubstance dependence wikipedia , lookup

Compounding wikipedia , lookup

Pharmaceutical marketing wikipedia , lookup

Electronic prescribing wikipedia , lookup

Psychedelic therapy wikipedia , lookup

Orphan drug wikipedia , lookup

Drug design wikipedia , lookup

Psychopharmacology wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Pharmacokinetics wikipedia , lookup

Pharmaceutical industry wikipedia , lookup

Pharmacognosy wikipedia , lookup

Drug interaction wikipedia , lookup

Bad Pharma wikipedia , lookup

Prescription costs wikipedia , lookup

Medication wikipedia , lookup

Drug discovery wikipedia , lookup

Neuropharmacology wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Transcript
May 12, 2016
Angelina College
Health Careers Division
RSPT 2317 Respiratory Care Pharmacology
General Syllabus
I.
BASIC COURSE INFORMATION:
A. Course Description:
RSPT 2317. Respiratory Care Pharmacology Three Credit hours. A study of drugs that affect the
cardiopulmonary systems. Emphasis on classification, route of administration, dosages/calculations,
physiological interactions. Forty-eight classroom hours. Learning Outcomes: Explain the mode of action,
clinical indications, dosages, hazards, and side effects of pulmonary and cardiovascular drugs; calculate drug
dosages; and select drugs for optimal therapeutic benefits.
B. Intended Audience: First-Year Students already enrolled in the Respiratory Care Program.
C. Instructor: Becky Renfrow-Freeze, MS, RRT, CPFT, CHT
Office Location: HCII 222A
Office Hours: 8:00 – 11:00 am Monday & Wednesday. Call Daphne Shepherd for appointment if not during
these hours
Phone: 936-633-5419
E-mail Address: [email protected]
II. INTENDED STUDENT OUTCOMES:
A. Core Objectives Required for this Course
1. Critical Thinking: to include creative thinking, innovation, inquiry, and analysis, evaluation and
synthesis of information
2. Communication: to include effective development, interpretation and expression of ideas through
written, oral and visual communication
3. Empirical and Quantitative Skills: to include the manipulation and analysis of numerical data or
observable facts resulting in informed conclusions
4. Teamwork: to include the ability to consider different points of view and to work effectively with others
to support a shared purpose or goal
5. Social Responsibility: to include the ability to connect choices, actions and consequences to ethical
decision-making
6. Personal Responsibility: to include intercultural competence, knowledge of civic responsibility, and
the ability to engage effectively in regional, national, and global communities
B. Course Learning Outcomes for all Sections
1. To define key terms related to pharmacologic principles.
2. To understand the metric system and drug dosage calculations.
3. To learn the various routes of drug administration, indications and hazards.
4. To introduce the student to the various cardiopulmonary diseases and the role the drugs play in their
treatment.
5. To learn general management techniques of various cardiopulmonary diseases.
C. Course Objectives as determined by the instructor –
III. ASSESSMENT MEASURES OF STUDENT LEARNING OUTCOMES:
A. Assessments for the Core Objectives:
1. Critical Thinking: to include creative thinking, innovation, inquiry, and analysis, evaluation and
synthesis of information
2. Communication: to include effective development, interpretation and expression of ideas through
written, oral and visual communication
3. Empirical and Quantitative Skills: to include the manipulation and analysis of numerical data or
observable facts resulting in informed conclusions
4. Teamwork: to include the ability to consider different points of view and to work effectively with others
to support a shared purpose or goal
5. Social Responsibility: to include the ability to connect choices, actions and consequences to ethical
decision-making
6. Personal Responsibility: to include intercultural competence, knowledge of civic responsibility, and
the ability to engage effectively in regional, national, and global communities
B. Assessments for Course Learning Outcomes
CORE COMPETENCIES: SCANS – (Secretary’s Commission on Academic Necessary Skills)
Students are expected to demonstrate basic competency in academic and workforce skills. The following
are competencies with evaluation are included in RSPT 1461.
SCAN Skills
Assessments
Foundation Skills
Written Assignments
Follow oral and written instructions
Decision making & problem solving
Mathematical Calculations
Oral Presentations
Required Readings
Critical Thinking Case Studies
Demonstrated Competency in Clinical
Workplace Competencies
Computer Assisted Instruction
Acquires and Evaluates Information
Applies technology
Written Care Plans
Demonstrated Competency in Clinical
IV. INSTRUCTIONAL PROCEDURES:
The methods of instruction used in this course includes but not limited to the following: Lecture, lab, discussion,
performance, audiovisual, computer assisted instruction and critical-thinking patient case studies.
V. COURSE REQUIREMENTS AND POLICIES:
A. Required Textbooks and Recommended Readings, Materials and Equipment
Wilkins,Stoller,Kacmarek,(2013) Egan’s Fundamentals of Respiratory Care (10th ED), Mosby. as reference.
Colbert, B. & Kennedy, B. (2012) Integrated Cardiopulmonary Pharmacology (3rd ED), Prentice Hall, as
reference.
The student will need a basic calculator (NO CELL phones) for simple mathematical calculations.
Cell phones must be turned off. There is to be no texting in class. The cell phone is not to be used
as a calculator. See cell phone usage policy. Attendance will be taken and affect the course grade.
(See handbook) A medical dictionary would be helpful but not required.
B. Course Policies – This course conforms to the policies of Angelina College as stated in the
Angelina College Handbook.
1. Academic Assistance – If you have a disability (as cited in Section 504 of the Rehabilitation Act of
1973 or Title II of the Americans with Disabilities Act of 1990) that may affect your participation in this
class, you should see Karen Bowser, Room 208 of the Student Center. At a post-secondary institution,
you must self-identify as a person with a disability; Ms. Bowser will assist you with the necessary
information to do so.
Angelina College admits students without regard to race, color, creed, sex, national origin, age,
religion, or disability. Inquiries concerning sex equity, disability or age should be directed to Mr. Steve
Hudman, Title IX coordinator at 936-633-5293, Angelina College Student Center, Room 205, email
[email protected].
2. Attendance – Attendance is required as per Angelina College Policy and will be recorded every day.
Any student with three (3) consecutive absences of four (4) cumulative absences may be dropped from
the class. Records will be turned in to the academic dean at the end of the semester. Do not assume
that non-attendance in class will always result in an instructor drop. You must officially drop a class
or risk receiving an F. This is official Angelina College Policy.
3. Additional Policies Established by the Instructor:
All exams and written assignments become the property of the Angelina College Respiratory Care
Program.
VI. COURSE OUTLINE: Description of the Course Activities including due dates, schedules, and
deadlines.
Assignments – Class meets Monday - Wednesday 1:00 PM – 4:00 PM
Unit One
June 1
June 20
June 22
June 27
June 29
July 6
Syllabus Review, Unit One lecture begins The Basics (Drug Information, Terms,
Abbreviations) Chapter 1 – General Pharmacologic Principles (28 pages),
Chapter 32 Egan’s will start
Chapter 3 – Autonomic Nervous System (20 pages); Egan’s 708------Chapter 4 – Medicated Aerosol Treatments (16 pages)
Exam 1 - Chapter 5 – Bronchodilators (26 pages); Egan’s 710-716
Chapter 6 – Mucokinetics and Surfactants (19 pages); Egan’s 716-719
Chapter 7 – Anti-Inflammatory and Antiasthmatic Agents (21 pages); Egan’s 719-724
Chapter 8 –Anti-Infective Agents (19 pages); Egan’s 724-7728
Exam #2 – First Oral Presentation of Drug
Chapter 9 – Cardiac Agents (22 pages)
Chapter 10 – Blood Pressure and Antithrombotic Agents (23 pages)
Chapter 11 - Neuromuscular, Sedative, Anesthetic, and Analgesic Agents(23 pgs)
Chapter 15 – Medications for Advanced Cardiovascular Life Support; Egan’s 810-814
Exam #3
Second Orals of Drugs & Review for Finals
July 7
Final
June 6
June 8
June 13
June 15
Unit 1 The Basics
After completion of this unit, the student will be able to:
1.
2.
3.
4.
5.
Define key terms related to pharmacological principles
Utilize drug-reference sources of information
Discuss advantages and disadvantages of different routes of administration
Describe the processes of drug absorption, distribution, metabolism, and elimination
Explain differences in pharmacokinetics, pharmacodynamics, and adverse effects of drugs in
pediatric, geriatric, pregnant, and breast-feeding patients.
6. Discuss factors that may alter a patient’s response to a drug.
7. Discuss principles of drug poisonings, adverse drug reactions, and interactions
8. Discuss responsibilities in drug administration
9. Describe the divisions of the central and peripheral nervous systems
10. Define key terms relative to pharmacology of the autonomic nervous system
11. Describe the anatomy, neurotransmitters, and receptors of the autonomic nervous system.
12. State four classifications of autonomic nervous system drugs on the basis of how and where
13. Relate the pharmacology of the autonomic nervous system to the "specific chapters" and drug
classifications.
14. Define key terms related to aerosol therapy.
15. Describe the main goals of aerosol therapy.
16. State the advantages and disadvantages of the inhalation route of administration.
17. Describe the factors that affect aerosol deposition.
18. List advantages and limitations for using a metered dose inhaler (MDI), small volume nebulizer
(SVN), and dry powder inhaler (DPI)
19. Describe the proper technique for using an MDI, SVN, and DPI
Unit 2 The Specific Drug Classifications
After completion of this unit, the student
1. Define key terms relative to bronchodilator pharmacotherapy.
2. Describe the neurological control of bronchial smooth muscle, including the sympathetic and
parasympathetic nerves, their chemical mediators, and how bronchodilation is achieved.
3. Differentiate bronchospasm and bronchoconstriction.
4. Describe three pharmacologic methods for bronchodilation (sympathomimetic, anticholinergic and
xanthine) and the mode of action of each.
5. State the indications, contraindications, adverse reactions, onset of action and dosage range for
each bronchodilator.
6. Recommend appropriate bronchodilator therapy for various patient situations, including drug,
dosage, frequency and route of delivery.
7. Describe appropriate techniques for monitoring the patient's response to bronchodilator therapy.
8. Define key terms related to mucokinetic and surfactant agents.
9. Describe the production, function, and clearance of mucus in the healthy lung.
10. State the indications for bland aerosols and mucolytic agents.
11. Compare and contrast the mechanisms of action of bland aerosol and mucolytic agents.
12. Describe how surface tension relates to oxygenation and work of breathing.
13. Describe the role of surfactant in the lungs and surfactant replacement agents.
14. Describe the mechanisms of action of expectorants and antitussive agents.
15. Describe the inflammatory process as it relates to airway disease.
16. List the chemical mediators involved in allergic reactions.
17. Discuss physiology of corticosteroids
18. Understand the differentiation between Gram-positive and Gram-negative bacteria.
19. Define key terms related to cardiac and renal agents.
20. Relate cardiovascular physiology to pharmacological treatments.
21. Define key terms related to blood pressure and thrombosis.
22. Relate cardiovascular physiology to pharmacological treatments.
23. Understand the variables that affect blood pressure.
24. Describe the clinical applications of neuromuscular blocking drugs.
25. Discuss the mechanisms of action of medications that are hypnotic, sedative, or anxiolytic and their
importance in cardiorespiratory practice.
26. List and describe the function of oxygen delivery devices.
27. Describe the effects of oxygen, helium, carbon dioxide, and nitric oxide therapy.
28. List the hazards of oxygen, helium, carbon dioxide, and nitric oxide therapy.
Unit 3 Putting it All Together in Management for Various Pulmonary Diseases
After completion of this unit, the student will be able to:
1. Explain the pathophysiology of chronic obstructive pulmonary disease (COPD)
2. Distinguish among the various forms of COPD.
3. Develop a pharmacologic regimen for asthma, chronic bronchitis, and emphysema.
4. Develop a monitoring and educational plan for asthma, chronic bronchitis, and emphysema.
5. Discuss pathogens associated with and diagnosis of: community-acquired pneumonia; hospitalacquired pneumonia; pharyngitis; croup; epiglottitis; tuberculosis; bronchitis; bronchiolitis.
6. Describe goals of pharmacotherapy and monitoring parameters for: community-acquired pneumonia;
hospital-acquired pneumonia; pharyngitis; croup; epiglottitis; tuberculosis; bronchitis; bronchiolitis.
7. Ask and find the answers to questions necessary to develop a therapeutic plan for an individual with
a respiratory infectious disease.
8. Discuss controversies in pharmacological treatment of respiratory infectious disease.
VII. EVALUATION AND GRADING:
A.
Grading Criteria –
1. Lecture:
Assignments/Quizes
Unit Examinations
Final Examination
35%
30%
20%
2. Oral Case Study (Two)
15%
3. Laboratory: Performance Evaluation (as needed).
B.
VIII.
Determination of Grade –
The alphabetic grading for this course is as follows:
A = 92 - 100
B = 83 - 91
C = 75 - 82
D = 70 - 74
F = 69 & below
SYLLABUS MODIFICATION:
The instructor may modify the provisions of the syllabus to meet individual class needs by informing the
class in advance as to the changes being made.
NOTICE

Safety Data Sheet (SDS) Book
A Safety Data Sheet is a document that contains information on the chemical make-up,
use, storage, handling, emergency procedures and potential health effects related to a
hazardous material. The SDS contains much more information about the material than
the label on the container. SDS’s are prepared and written by the manufacturer of the
material.
The SDS sheets are accessible at all times & are kept in the following location(s):
Health Careers II:
A.
B.
C.
D.

Radiography Lab: Room
Sonography Lab: Room
Respiratory Lab: Room
Pharmacy Lab: Room
Plan & Procedures Book (Includes the following)
These reference items are accessible at all times & are kept in the following location(s):
Health Careers II: In the main office
1. Plans
 Universal Waste Plan
 Hazardous Waste Plan
 Chemical Waste Plan
 Exposure Control Plan
2. Procedures
 Battery Disposal
 Lamp Disposal
 Pesticide Disposal
 Mercury Containing Equipment Disposal
 Paint & Paint Related Waste Disposal
 Electronic Waste Disposal
 Medical Waste Disposal
 Chemical Waste Disposal
 Spill Cleanup